Susan Weiss
Family · Brooklyn, NYNPI 1073680690
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Viiv Healthcare Company accounts for 69.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $8,431 and has fallen 85.4% since, to $1,234 in 2025. Among family clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 259 payments — averaging $85.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$15K
- Gilead$3K
- Merck$2K
- Johnson & Johnson$705
- Theratechnologies Inc.$496
- Janssen Scientific Affairs, LLC$351
- plus $351 from 3 others
What the payments were for
- Consulting fees$9,53343%
- Travel & lodging$2,27710%
- Food & beverage$10,23846%
- Education$1100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 137 | $15,320 |
| Gilead | 58 | $3,312 |
| Merck | 20 | $1,624 |
| Johnson & Johnson | 28 | $705 |
| Theratechnologies Inc. | 5 | $496 |
| Janssen Scientific Affairs, LLC | 4 | $351 |
| Janssen Products, LP | 3 | $228 |
| EMD Serono, Inc. | 3 | $92 |
| Pfizer | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,157 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 301 | $1,162,862 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 37 | $140,077 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 37 | $128,420 |
| TivicayDolutegravir Sodium | 49 | $103,072 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 27 | $99,679 |
| JulucaDolutegravir/Rilpivirine | 29 | $98,264 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 16 | $70,341 |
| DescovyEmtricitabine/Tenofov Alafenam | 31 | $63,834 |
| PifeltroDoravirine | 25 | $42,186 |
| PrezcobixDarunavir/Cobicistat | 13 | $29,485 |
| JanuviaSitagliptin Phosphate | 43 | $27,978 |
| JardianceEmpagliflozin | 32 | $21,016 |
| EliquisApixaban | 26 | $14,805 |
| XareltoRivaroxaban | 13 | $7,246 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 13 | $6,946 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Genvoya, Descovy | $3,312 | $1,366,773369 claims |
| Viiv Healthcare CompanyTivicay, Triumeq, Juluca | $15,320 | $301,014105 claims |
| MerckPifeltro, Januvia, Janumet Xr | $1,624 | $77,11081 claims |
| Janssen Products, LPSymtuza | $228 | $70,34116 claims |
| Johnson & JohnsonPrezcobix, Xarelto | $705 | $36,73226 claims |
| PfizerEliquis | $31 | $14,80526 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,883 family providers in New York.
Other family in Brooklyn
- Seida VelijaBrooklyn$62K
- Ofiong OkonBrooklyn$44K
- Irina FainbergBrooklyn$23K
- Razan AlawadhiBrooklyn$21K
- Christina LaoBrooklyn$20K
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.